108 related articles for article (PubMed ID: 19066472)
1. Tyrosine phosphatase SHP-2 is a regulator of p27(Kip1) tyrosine phosphorylation.
Tossidou I; Dangers M; Koch A; Brandt DT; Schiffer M; Kardinal C
Cell Cycle; 2008 Dec; 7(24):3858-68. PubMed ID: 19066472
[TBL] [Abstract][Full Text] [Related]
2. The SH2 domain-containing protein tyrosine phosphatase SHP-1 is induced by granulocyte colony-stimulating factor (G-CSF) and modulates signaling from the G-CSF receptor.
Ward AC; Oomen SP; Smith L; Gits J; van Leeuwen D; Soede-Bobok AA; Erpelinck-Verschueren CA; Yi T; Touw IP
Leukemia; 2000 Jul; 14(7):1284-91. PubMed ID: 10914554
[TBL] [Abstract][Full Text] [Related]
3. Tyrosine phosphorylation modulates binding preference to cyclin-dependent kinases and subcellular localization of p27Kip1 in the acute promyelocytic leukemia cell line NB4.
Kardinal C; Dangers M; Kardinal A; Koch A; Brandt DT; Tamura T; Welte K
Blood; 2006 Feb; 107(3):1133-40. PubMed ID: 16195327
[TBL] [Abstract][Full Text] [Related]
4. Knockdown of protein tyrosine phosphatase SHP-1 inhibits G1/S progression in prostate cancer cells through the regulation of components of the cell-cycle machinery.
Rodríguez-Ubreva FJ; Cariaga-Martinez AE; Cortés MA; Romero-De Pablos M; Ropero S; López-Ruiz P; Colás B
Oncogene; 2010 Jan; 29(3):345-55. PubMed ID: 19838216
[TBL] [Abstract][Full Text] [Related]
5. Phosphorylation of p27Kip1 by JAK2 directly links cytokine receptor signaling to cell cycle control.
Jäkel H; Weinl C; Hengst L
Oncogene; 2011 Aug; 30(32):3502-12. PubMed ID: 21423214
[TBL] [Abstract][Full Text] [Related]
6. STAT3-mediated differentiation and survival and of myeloid cells in response to granulocyte colony-stimulating factor: role for the cyclin-dependent kinase inhibitor p27(Kip1).
de Koning JP; Soede-Bobok AA; Ward AC; Schelen AM; Antonissen C; van Leeuwen D; Löwenberg B; Touw IP
Oncogene; 2000 Jul; 19(29):3290-8. PubMed ID: 10918585
[TBL] [Abstract][Full Text] [Related]
7. The phosphotyrosine phosphatase SHP-2 participates in a multimeric signaling complex and regulates T cell receptor (TCR) coupling to the Ras/mitogen-activated protein kinase (MAPK) pathway in Jurkat T cells.
Frearson JA; Alexander DR
J Exp Med; 1998 May; 187(9):1417-26. PubMed ID: 9565634
[TBL] [Abstract][Full Text] [Related]
8. Effects of Src homology domain 2 (SH2)-containing inositol phosphatase (SHIP), SH2-containing phosphotyrosine phosphatase (SHP)-1, and SHP-2 SH2 decoy proteins on Fc gamma RIIB1-effector interactions and inhibitory functions.
Nakamura K; Brauweiler A; Cambier JC
J Immunol; 2000 Jan; 164(2):631-8. PubMed ID: 10623804
[TBL] [Abstract][Full Text] [Related]
9. Src homology region 2 (SH2) domain-containing phosphatase-1 dephosphorylates B cell linker protein/SH2 domain leukocyte protein of 65 kDa and selectively regulates c-Jun NH2-terminal kinase activation in B cells.
Mizuno K; Tagawa Y; Mitomo K; Arimura Y; Hatano N; Katagiri T; Ogimoto M; Yakura H
J Immunol; 2000 Aug; 165(3):1344-51. PubMed ID: 10903736
[TBL] [Abstract][Full Text] [Related]
10. BCR-ABL induces the expression of Skp2 through the PI3K pathway to promote p27Kip1 degradation and proliferation of chronic myelogenous leukemia cells.
Andreu EJ; Lledó E; Poch E; Ivorra C; Albero MP; Martínez-Climent JA; Montiel-Duarte C; Rifón J; Pérez-Calvo J; Arbona C; Prósper F; Pérez-Roger I
Cancer Res; 2005 Apr; 65(8):3264-72. PubMed ID: 15833859
[TBL] [Abstract][Full Text] [Related]
11. Pim kinases promote cell cycle progression by phosphorylating and down-regulating p27Kip1 at the transcriptional and posttranscriptional levels.
Morishita D; Katayama R; Sekimizu K; Tsuruo T; Fujita N
Cancer Res; 2008 Jul; 68(13):5076-85. PubMed ID: 18593906
[TBL] [Abstract][Full Text] [Related]
12. WIP1 dephosphorylation of p27
Choi BK; Fujiwara K; Dayaram T; Darlington Y; Dickerson J; Goodell MA; Donehower LA
Cell Cycle; 2020 Feb; 19(4):479-491. PubMed ID: 31959038
[TBL] [Abstract][Full Text] [Related]
13. Direct binding of Shc, Grb2, SHP-2 and p40 to the murine granulocyte colony-stimulating factor receptor.
Ward AC; Monkhouse JL; Hamilton JA; Csar XF
Biochim Biophys Acta; 1998 Nov; 1448(1):70-6. PubMed ID: 9824671
[TBL] [Abstract][Full Text] [Related]
14. The alphaVbeta3 integrin regulates insulin-like growth factor I (IGF-I) receptor phosphorylation by altering the rate of recruitment of the Src-homology 2-containing phosphotyrosine phosphatase-2 to the activated IGF-I receptor.
Maile LA; Clemmons DR
Endocrinology; 2002 Nov; 143(11):4259-64. PubMed ID: 12399420
[TBL] [Abstract][Full Text] [Related]
15. The inhibition of activated hepatic stellate cells proliferation by arctigenin through G0/G1 phase cell cycle arrest: persistent p27(Kip1) induction by interfering with PI3K/Akt/FOXO3a signaling pathway.
Li A; Wang J; Wu M; Zhang X; Zhang H
Eur J Pharmacol; 2015 Jan; 747():71-87. PubMed ID: 25498792
[TBL] [Abstract][Full Text] [Related]
16. Regulated expression of cofilin and the consequent regulation of p27(kip1) are essential for G(1) phase progression.
Tsai CH; Chiu SJ; Liu CC; Sheu TJ; Hsieh CH; Keng PC; Lee YJ
Cell Cycle; 2009 Aug; 8(15):2365-74. PubMed ID: 19556892
[TBL] [Abstract][Full Text] [Related]
17. Cyclin D1 regulates p27(Kip1) stability in B cells.
Bustany S; Tchakarska G; Sola B
Cell Signal; 2011 Jan; 23(1):171-9. PubMed ID: 20837141
[TBL] [Abstract][Full Text] [Related]
18. A growth factor-dependent nuclear kinase phosphorylates p27(Kip1) and regulates cell cycle progression.
Boehm M; Yoshimoto T; Crook MF; Nallamshetty S; True A; Nabel GJ; Nabel EG
EMBO J; 2002 Jul; 21(13):3390-401. PubMed ID: 12093740
[TBL] [Abstract][Full Text] [Related]
19. B cell antigen receptor (BCR)-mediated formation of a SHP-2-pp120 complex and its inhibition by Fc gamma RIIB1-BCR coligation.
Nakamura K; Cambier JC
J Immunol; 1998 Jul; 161(2):684-91. PubMed ID: 9670943
[TBL] [Abstract][Full Text] [Related]
20. Erlotinib, an effective epidermal growth factor receptor tyrosine kinase inhibitor, induces p27KIP1 up-regulation and nuclear translocation in association with cell growth inhibition and G1/S phase arrest in human non-small-cell lung cancer cell lines.
Ling YH; Li T; Yuan Z; Haigentz M; Weber TK; Perez-Soler R
Mol Pharmacol; 2007 Aug; 72(2):248-58. PubMed ID: 17456787
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
